Madrigal Pharmaceuticals financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

매드리걸 파머슈티컬스NASDAQ:MDGL · Nasdaq · Healthcare

$499.40-0.06%

2026-10-02 close

Madrigal Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $180M. 2024 operating profit was −$498M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy